Balance Sheet Chison Medical Technologies Co., Ltd.

Equities

688358

CNE1000076R4

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E. Other stock markets 12/03/2026			5-day change	1st Jan Change
31.44 ^CNY	-2.03%		+0.51%	+4.45%

02-27	Chison Medical Technologies Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
12-15	Chison Medical Technologies Delays Two IPO-Funded Projects	MT

26c7.Qzy5HvMDE5OU8gISp5f3r3Jl57g912h6fqVcKE63yww.Mgj8KZc1VsXQkWkjkPC58ERdr_1t-iJJCvYpGH7u_T1uU8lUxXFxxdaXSw

Published financial data: CHISON MEDICAL TECHNOLOGIES CO., LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	329M	395M	376M	481M	468M
Other Revenues, Total	4.07M	2.9M	5.16M	2.95M	572K
Total Revenues	333M	398M	381M	484M	469M
Cost of Goods Sold, Total	139M	179M	161M	208M	197M
Gross Profit	194M	219M	220M	275M	272M
Selling General & Admin Expenses, Total	56.91M	76.15M	81.84M	84.26M	92.63M
Provision for Bad Debts	1.14M	738K	-1.4M	3.58M	1.7M
R&D Expenses	55.64M	72.29M	77.88M	77.07M	79.63M
Other Operating Expenses	-2.01M	-2.49M	-4.3M	-3.43M	-2.68M
Other Operating Expenses, Total	112M	147M	154M	161M	171M
Operating Income	82.21M	72.24M	66.22M	114M	100M
Interest Expense, Total	-	-68.45K	-110K	-357K	-379K
Interest And Investment Income	27.82M	19.59M	16.43M	29.6M	37.32M
Net Interest Expenses	27.82M	19.52M	16.32M	29.24M	36.94M
Currency Exchange Gains (Loss)	-8.54M	-6.02M	26.13M	5.49M	10.48M
Other Non Operating Income (Expenses)	-274K	-374K	-383K	-384K	-626K
EBT, Excl. Unusual Items	101M	85.37M	108M	148M	147M
Gain (Loss) On Sale Of Investments	-	425K	-1.37M	2.93M	171K
Gain (Loss) On Sale Of Assets	12.29K	30.26M	-503K	3.02M	4.61M
Asset Writedown	-	-1.59M	-506K	-61.61K	-
Other Unusual Items	10.28M	10.08M	9.22M	7.94M	4.8M
EBT, Incl. Unusual Items	112M	125M	115M	162M	157M
Income Tax Expense	11.88M	12.07M	9.29M	15.71M	16.34M
Earnings From Continuing Operations	99.64M	112M	106M	146M	141M
Net Income to Company	99.64M	112M	106M	146M	141M
Net Income - (IS)	99.64M	112M	106M	146M	141M
Net Income to Common Incl Extra Items	99.64M	112M	106M	146M	141M
Net Income to Common Excl. Extra Items	99.64M	112M	106M	146M	141M
Per Share Items
Net EPS - Basic	0.89	1.01	0.94	1.33	1.26
Basic EPS - Continuing Operations	0.89	1.01	0.94	1.33	1.26
Basic Weighted Average Shares Outstanding	112M	112M	113M	110M	112M
Net EPS - Diluted	0.89	1.01	0.94	1.33	1.26
Diluted EPS - Continuing Operations	0.89	1.01	0.94	1.33	1.26
Diluted Weighted Average Shares Outstanding	112M	112M	113M	110M	112M
Normalized Basic EPS	0.57	0.48	0.6	0.84	0.83
Normalized Diluted EPS	0.57	0.48	0.6	0.84	0.83
Dividend Per Share	0.57	0.36	0.7	0.8	1
Payout Ratio	80.29	56.9	37.79	53.58	63.7
Supplemental Items
EBITDA	89.83M	80.9M	77.6M	125M	112M
EBITA	82.71M	72.74M	66.69M	114M	101M
EBIT	82.21M	72.24M	66.22M	114M	100M
EBITDAR	90.32M	81.4M	78.07M	127M	113M
Total Revenues (As Reported)	333M	398M	381M	484M	469M
Effective Tax Rate - (Ratio)	10.65	9.69	8.07	9.69	10.42
Total Current Taxes	12.87M	13.19M	11.67M	14.93M	15.53M
Total Deferred Taxes	-990K	-1.12M	-2.39M	787K	815K
Normalized Net Income	63.26M	53.35M	67.68M	92.73M	92.04M
Interest on Long-Term Debt	-	-	-	357K	379K
Supplemental Operating Expense Items
Advertising Expense	4.66M	4.1M	2.64M	3.38M	5.27M
Selling and Marketing Expenses	36.8M	47.92M	48.54M	49.33M	55M
General and Administrative Expenses	20.11M	28.23M	33.3M	34.93M	37.63M
Research And Development Expense From Footnotes	55.64M	72.29M	77.88M	77.07M	79.63M
Net Rental Expense, Total	497K	495K	470K	1.76M	1.77M
Imputed Operating Lease Interest Expense	-	-	110K	612K	635K
Imputed Operating Lease Depreciation	-	-	359K	1.15M	1.13M
Maintenance & Repair Expenses, Total	1.6M	1.9M	1.75M	3.5M	-
Stock-Based Comp., R&D Exp. (Total)	647K	2.4M	-	-	-
Stock-Based Comp., S&M Exp. (Total)	1.55M	1.46M	-	-	-
Stock-Based Comp., G&A Exp. (Total)	239K	344K	-	-	-
Stock-Based Comp., Other (Total)	-	-	63.27K	-2.34M	-1.41M
Total Stock-Based Compensation	2.44M	4.21M	63.27K	-2.34M	-1.41M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	302M	446M	446M	689M	986M
Trading Asset Securities, Total	745M	580M	581M	341M	115M
Total Cash And Short Term Investments	1.05B	1.03B	1.03B	1.03B	1.1B
Accounts Receivable, Total	126M	136M	93.52M	155M	162M
Other Receivables	2.44M	1.65M	3.68M	3.47M	2.44M
Total Receivables	129M	137M	97.2M	158M	164M
Inventory	84.09M	99.45M	197M	136M	126M
Prepaid Expenses	-	-	-	-	-
Other Current Assets, Total	10.98M	7.11M	17.46M	18.06M	13.78M
Total Current Assets	1.27B	1.27B	1.34B	1.34B	1.41B
Gross Property Plant And Equipment	94.13M	145M	198M	215M	243M
Accumulated Depreciation	-47.67M	-50.15M	-60.87M	-72.1M	-85.32M
Net Property Plant And Equipment	46.46M	94.48M	137M	143M	158M
Other Intangibles, Total	23.84M	22.54M	22.06M	21.07M	20.43M
Deferred Tax Assets Long-Term	6.55M	7.67M	10.21M	9.27M	8.45M
Deferred Charges Long-Term	372K	134K	3.04K	690K	881K
Other Long-Term Assets, Total	1.73M	2.94M	5.5M	6.89M	4.49M
Total Assets	1.35B	1.4B	1.51B	1.52B	1.6B
Liabilities
Accounts Payable, Total	66.91M	53.89M	92.09M	66.91M	68.32M
Accrued Expenses, Total	27.35M	32.75M	36.98M	32.09M	33.12M
Current Portion of Leases	-	582K	311K	4.02M	3.86M
Current Income Taxes Payable	2.48M	3.84M	2.15M	3.26M	6.59M
Unearned Revenue Current, Total	26.84M	25.21M	22.99M	16M	30.7M
Other Current Liabilities	5.47M	23.45M	33.94M	16.11M	24.19M
Total Current Liabilities	129M	140M	188M	138M	167M
Long-Term Leases	-	786K	5.8M	6.32M	2.67M
Unearned Revenue Non Current	8.06M	3.54M	1.85M	2.3M	808K
Deferred Tax Liability Non Current	-	-	153K	-	-
Other Non Current Liabilities	19.6M	8.43M	4.15M	6.41M	6.16M
Total Liabilities	157M	152M	200M	153M	176M
Common Stock, Total	80M	80M	112M	112M	112M
Additional Paid In Capital	933M	938M	908M	905M	904M
Retained Earnings	180M	228M	294M	362M	413M
Treasury Stock	-	-	-	-10.09M	-10.09M
Comprehensive Income and Other	-223K	-225K	-223K	-222K	1.7M
Total Common Equity	1.19B	1.25B	1.31B	1.37B	1.42B
Total Equity	1.19B	1.25B	1.31B	1.37B	1.42B
Total Liabilities And Equity	1.35B	1.4B	1.51B	1.52B	1.6B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	112M	112M	112M	112M	112M
ECS Total Common Shares Outstanding	112M	112M	112M	112M	112M
Book Value / Share	10.65	11.12	11.71	12.21	12.7
Tangible Book Value	1.17B	1.22B	1.29B	1.35B	1.4B
Tangible Book Value Per Share	10.44	10.92	11.52	12.02	12.52
Total Debt	0	1.37M	6.11M	10.34M	6.53M
Net Debt	-1.05B	-1.02B	-1.02B	-1.02B	-1.09B
Debt Equivalent Oper. Leases	3.97M	3.96M	3.76M	14.09M	14.13M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	35.59M	51.01M	77.3M	57.91M	46.74M
Inventories - Work In Process, Total	18.58M	21.32M	33.09M	31.07M	31.67M
Inventories - Finished Goods, Total	33.35M	31.69M	94.07M	59.56M	64.25M
Inventories - Others	126K	389K	358K	201K	427K
Buildings, Total	17.47M	66.75M	67.53M	73.28M	73.38M
Machinery, Total	58.08M	67.29M	71.87M	75.2M	81.95M
Full Time Employees	538	636	605	536	537
Accumulated Allowance for Doubtful Accounts (Supple)	7.07M	7.8M	6.41M	9.98M	11.69M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	99.64M	112M	106M	146M	141M
Depreciation & Amortization - CF	7.12M	8.76M	11.86M	13.28M	13.85M
Amortization of Goodwill and Intangible Assets - (CF)	497K	495K	470K	448K	470K
Depreciation & Amortization, Total	7.62M	9.26M	12.33M	13.72M	14.32M
Amortization of Deferred Charges, Total - (CF)	810K	869K	829K	576K	715K
(Gain) Loss From Sale Of Asset	-12.29K	-30.25M	503K	-3.02M	-4.61M
(Gain) Loss on Sale of Investments - (CF)	-27.22M	-17.53M	-15M	-11.17M	-6.29M
Asset Writedown & Restructuring Costs	-	1.58M	506K	61.61K	-
Provision and Write-off of Bad Debts	1.14M	738K	-1.4M	3.58M	1.7M
Other Operating Activities, Total	3.24M	6.22M	-15.19M	-19.06M	-16.92M
Change In Accounts Receivable	-27.14M	-1.55M	37.02M	-78.87M	-1.01M
Change In Inventories	-25.41M	-16.76M	-100M	56.08M	5.65M
Change In Accounts Payable	48.33M	-25.33M	41.92M	-20.33M	7.83M
Change In Deferred Taxes	-990K	-1.12M	-2.39M	787K	815K
Change in Other Net Operating Assets	2.44M	1.37M	-819K	-2.92M	-2.03M
Cash from Operations	82.45M	39.96M	63.74M	85.91M	141M
Capital Expenditure	-30.88M	-39.19M	-52.21M	-34.01M	-8.85M
Sale of Property, Plant, and Equipment	58.41K	21.17M	86.38K	3.71M	5.01M
Investment in Marketable and Equity Securities, Total	-745M	165M	0	-236M	536M
Other Investing Activities, Total	27.22M	17.1M	6.69M	25.15M	23.68M
Cash from Investing	-749M	164M	-45.43M	-241M	556M
Long-Term Debt Repaid, Total	-	-613K	-925K	-946K	-4.3M
Total Debt Repaid	-	-613K	-925K	-946K	-4.3M
Issuance of Common Stock	-	-	2.02M	-	-
Repurchase of Common Stock	-	-	-	-10.1M	-
Common Dividends Paid	-80M	-64M	-40M	-78.49M	-89.5M
Common & Preferred Stock Dividends Paid	-80M	-64M	-40M	-78.49M	-89.5M
Other Financing Activities, Total	-11.18M	-	-	-	-
Cash from Financing	-91.18M	-64.61M	-38.91M	-89.53M	-93.8M
Foreign Exchange Rate Adjustments	-3.62M	-2.99M	21.59M	9.34M	12.24M
Net Change in Cash	-761M	136M	990K	-235M	615M
Supplemental Items
Cash Income Tax Paid (Refund)	429K	-14.31M	-6.43M	476K	-2.42M
Levered Free Cash Flow	18.7M	9.94M	-16.24M	-5.19M	104M
Unlevered Free Cash Flow	18.7M	9.99M	-16.18M	-4.97M	104M
Change In Net Working Capital	12.66M	10.31M	18.58M	54.18M	-36.31M
Net Debt Issued / Repaid	-	-613K	-925K	-946K	-4.3M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	3.89	3.29	2.84	4.69	4.03
Return on Total Capital	4.35	3.7	3.23	5.28	4.47
Return On Equity %	8.43	9.22	8.27	10.92	10.07
Return on Common Equity	8.43	9.22	8.27	10.92	10.07
Margin Analysis
Gross Profit Margin %	58.21	55.03	57.83	56.94	57.98
SG&A Margin	17.08	19.14	21.49	17.41	19.76
EBITDA Margin %	26.97	20.34	20.38	25.86	23.84
EBITA Margin %	24.83	18.28	17.51	23.66	21.54
EBIT Margin %	24.68	18.16	17.39	23.56	21.44
Income From Continuing Operations Margin %	29.91	28.27	27.79	30.27	29.98
Net Income Margin %	29.91	28.27	27.79	30.27	29.98
Net Avail. For Common Margin %	29.91	28.27	27.79	30.27	29.98
Normalized Net Income Margin	18.99	13.41	17.77	19.16	19.64
Levered Free Cash Flow Margin	5.61	2.5	-4.27	-1.07	22.11
Unlevered Free Cash Flow Margin	5.61	2.51	-4.25	-1.03	22.16
Asset Turnover
Asset Turnover	0.25	0.29	0.26	0.32	0.3
Fixed Assets Turnover	9.65	5.64	3.29	3.45	3.11
Receivables Turnover (Average Receivables)	2.82	3.02	3.28	3.88	2.96
Inventory Turnover (Average Inventory)	1.96	1.95	1.08	1.25	1.5
Short Term Liquidity
Current Ratio	9.85	9.09	7.1	9.69	8.42
Quick Ratio	9.11	8.33	5.97	8.58	7.58
Operating Cash Flow to Current Liabilities	0.64	0.29	0.34	0.62	0.84
Days Sales Outstanding (Average Receivables)	129.58	121.03	111.4	94.14	123.62
Days Outstanding Inventory (Average Inventory)	187.2	187.25	336.82	291.59	243.69
Average Days Payable Outstanding	128.08	113.5	103.22	196.98	132.1
Cash Conversion Cycle (Average Days)	188.7	194.78	345	188.75	235.21
Long Term Solvency
Total Debt/Equity	-	0.11	0.47	0.76	0.46
Total Debt / Total Capital	-	0.11	0.46	0.75	0.46
LT Debt/Equity	-	0.06	0.44	0.46	0.19
Long-Term Debt / Total Capital	-	0.06	0.44	0.46	0.19
Total Liabilities / Total Assets	11.61	10.91	13.24	10.08	11.05
EBIT / Interest Expense	-	1.06K	603.27	319.06	265.26
EBITDA / Interest Expense	-	1.19K	715.62	357.47	303.07
(EBITDA - Capex) / Interest Expense	-	618.19	240.01	262.29	279.7
Total Debt / EBITDA	-	0.02	0.08	0.08	0.06
Net Debt / EBITDA	-11.66	-12.58	-13	-7.98	-9.53
Total Debt / (EBITDA - Capex)	-	0.03	0.23	0.11	0.06
Net Debt / (EBITDA - Capex)	-17.76	-24.22	-38.76	-10.87	-10.33
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-9.92	19.43	-4.27	27.04	-3.13
Gross Profit, 1 Yr. Growth %	-13.24	12.92	0.6	25.09	-1.36
EBITDA, 1 Yr. Growth %	-18.24	-10.5	-4.82	59.83	-11.1
EBITA, 1 Yr. Growth %	-20.68	-12.66	-9.1	69.85	-12.23
EBIT, 1 Yr. Growth %	-20.37	-12.12	-8.33	72.17	-11.88
Earnings From Cont. Operations, 1 Yr. Growth %	-5.23	12.88	-5.89	38.39	-4.08
Net Income, 1 Yr. Growth %	-5.23	12.88	-5.89	38.39	-4.08
Normalized Net Income, 1 Yr. Growth %	-7.1	-15.66	26.85	37.01	-0.74
Diluted EPS Before Extra, 1 Yr. Growth %	-26.47	12.79	-6	41.49	-5.26
Accounts Receivable, 1 Yr. Growth %	17.97	7.71	-31.14	65.25	4.62
Inventory, 1 Yr. Growth %	44.21	18.26	98.04	-30.99	-7.06
Net Property, Plant and Equip., 1 Yr. Growth %	105.97	103.35	45.35	4.3	10.11
Total Assets, 1 Yr. Growth %	4.58	3.59	8.29	0.57	4.89
Tangible Book Value, 1 Yr. Growth %	1.97	4.62	5.59	4.38	3.87
Common Equity, 1 Yr. Growth %	1.89	4.42	5.45	4.23	3.76
Cash From Operations, 1 Yr. Growth %	3.28	-51.53	59.51	34.78	63.76
Capital Expenditures, 1 Yr. Growth %	296.34	26.88	33.24	-34.86	-73.97
Levered Free Cash Flow, 1 Yr. Growth %	-38.44	-46.82	-383.09	-68.16	-3.73K
Unlevered Free Cash Flow, 1 Yr. Growth %	-38.44	-46.59	-379.81	-69.41	-4.05K
Dividend Per Share, 1 Yr. Growth %	-20.01	-37.5	96.02	14.29	25
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	0.93	3.72	6.93	10.28	10.94
Gross Profit, 2 Yr. CAGR %	-0.82	-1.02	6.58	12.18	11.08
EBITDA, 2 Yr. CAGR %	-7.56	-14.19	-7.35	23.89	19.46
EBITA, 2 Yr. CAGR %	-9.14	-16.48	-10.51	24.91	22.38
EBIT, 2 Yr. CAGR %	-8.98	-16.35	-10.25	25.63	23.17
Earnings From Cont. Operations, 2 Yr. CAGR %	2.38	3.43	3.07	14.12	15.22
Net Income, 2 Yr. CAGR %	2.38	3.43	3.07	14.12	15.22
Normalized Net Income, 2 Yr. CAGR %	-0.34	-11.49	3.43	31.83	16.61
Diluted EPS Before Extra, 2 Yr. CAGR %	-11.05	-8.93	2.6	15.33	15.78
Accounts Receivable, 2 Yr. CAGR %	55.66	12.72	-13.88	6.68	31.49
Inventory, 2 Yr. CAGR %	18.6	30.59	53.04	16.91	-19.91
Net Property, Plant and Equip., 2 Yr. CAGR %	44.98	104.66	71.92	23.13	7.17
Total Assets, 2 Yr. CAGR %	104.25	4.08	5.91	4.35	2.71
Tangible Book Value, 2 Yr. CAGR %	151.97	3.29	5.1	4.98	4.12
Common Equity, 2 Yr. CAGR %	138.81	3.14	4.93	4.84	4
Cash From Operations, 2 Yr. CAGR %	7.45	-29.25	-12.07	46.62	48.56
Capital Expenditures, 2 Yr. CAGR %	131.34	124.25	30.02	-6.84	-58.82
Levered Free Cash Flow, 2 Yr. CAGR %	-33.14	-42.78	-6.79	-4.88	152.09
Unlevered Free Cash Flow, 2 Yr. CAGR %	-33.14	-42.66	-6.99	-7.3	152.91
Dividend Per Share, 2 Yr. CAGR %	-	-29.29	10.68	49.68	19.52
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	7.04	6.76	0.99	13.25	5.62
Gross Profit, 3 Yr. CAGR %	6.65	3.56	-0.48	12.42	7.47
EBITDA, 3 Yr. CAGR %	5	-8.36	-10.94	11.45	11.07
EBITA, 3 Yr. CAGR %	4.22	-10.12	-13.84	11.19	11.22
EBIT, 3 Yr. CAGR %	4.07	-10.04	-13.76	11.52	11.62
Earnings From Cont. Operations, 3 Yr. CAGR %	15.87	5.77	0.22	13.71	7.7
Net Income, 3 Yr. CAGR %	15.87	5.77	0.22	13.71	7.7
Normalized Net Income, 3 Yr. CAGR %	14.46	-5.73	-0.21	13.59	19.93
Diluted EPS Before Extra, 3 Yr. CAGR %	5.32	-3.73	-8.18	14.2	8.01
Accounts Receivable, 3 Yr. CAGR %	43.97	37.68	-4.35	7.02	5.99
Inventory, 3 Yr. CAGR %	21.55	18.48	50.04	17.36	8.3
Net Property, Plant and Equip., 3 Yr. CAGR %	28.92	62.29	82.6	45.54	18.63
Total Assets, 3 Yr. CAGR %	78.38	62.89	5.47	4.1	4.53
Tangible Book Value, 3 Yr. CAGR %	114.21	87.97	4.05	4.86	4.61
Common Equity, 3 Yr. CAGR %	102.26	81.25	3.91	4.7	4.48
Cash From Operations, 3 Yr. CAGR %	9.85	-17.6	-7.23	1.38	52.13
Capital Expenditures, 3 Yr. CAGR %	29.6	89.36	88.52	3.27	-39.09
Levered Free Cash Flow, 3 Yr. CAGR %	17.84	-38.05	-18.83	-34.76	162.37
Unlevered Free Cash Flow, 3 Yr. CAGR %	17.84	-37.96	-18.94	-35.71	161.92
Dividend Per Share, 3 Yr. CAGR %	-	-	-0.67	11.87	40.95
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	18.96	6.99	8.15	4.86
Gross Profit, 5 Yr. CAGR %	-	18.25	6.62	6.93	3.99
EBITDA, 5 Yr. CAGR %	-	23.95	0	3.55	0.34
EBITA, 5 Yr. CAGR %	-	25.74	-1.81	2.7	-0.65
EBIT, 5 Yr. CAGR %	-	25.63	-1.91	2.82	-0.54
Earnings From Cont. Operations, 5 Yr. CAGR %	-	29.85	10.57	9.03	5.97
Net Income, 5 Yr. CAGR %	-	29.85	10.57	9.03	5.97
Normalized Net Income, 5 Yr. CAGR %	-	26.43	9.91	7.8	6.21
Diluted EPS Before Extra, 5 Yr. CAGR %	-	22.55	4.23	3.34	0.74
Accounts Receivable, 5 Yr. CAGR %	-	40.26	17.22	24.32	8.63
Inventory, 5 Yr. CAGR %	-	19.76	33.28	17.85	16.72
Net Property, Plant and Equip., 5 Yr. CAGR %	-	34.73	44.66	45.32	47.54
Total Assets, 5 Yr. CAGR %	-	55.65	44.8	36.31	4.35
Tangible Book Value, 5 Yr. CAGR %	-	75.24	61.12	48.9	4.08
Common Equity, 5 Yr. CAGR %	-	74.8	55.56	45.61	3.94
Cash From Operations, 5 Yr. CAGR %	-	-1.06	0.49	3.76	12
Capital Expenditures, 5 Yr. CAGR %	-	39.35	29.77	42.58	2.59
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	7.29	-34.12	27.82
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	7.2	-34.69	27.88
Dividend Per Share, 5 Yr. CAGR %	-	-	-	-	6.96